Skip to content

A clinical study of two different non-invasive interventions on clearing high-risk human papilloma virus persistent infection

A clinical study of two different non-invasive interventions on clearing high-risk human papilloma virus persistent infection

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045911
Enrollment
Unknown
Registered
2021-04-28
Start date
2019-06-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-risk HPV persistent infection

Interventions

Sponsors

Anhui Province Maternity and Child Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 18 to 70 years with sexual life, but non-pregnant or lactating; 2. Persistent hr-HPV infection for more than twelve months; 3. For each individual patient, only either HPV genotyping test or HPV E6/E7 mRNA assay was used for the examination of hrHPV infection during whole observation from the screening of enrollment to the end of follow-up; 4. Without a high level of cervical lesions [no more than grade one cervical intraepithelial neoplasia (CIN I) according to the examination of colposcopy and biopsy]; 5. No previous anti-HPV intervention.

Exclusion criteria

Exclusion criteria: 1. With a history of allergy, smoking, oral contraceptive, and HPV vaccination; 2. With severe heart, lung, liver, and kidney dysfunction; 3. Women who can't complete the designed drug administration due to menstrual disorder.

Design outcomes

Primary

MeasureTime frame
HPV E6E7 mRNA;HPV-DNA genotyping test;

Countries

China

Contacts

Public ContactZhou Shuguang

Anhui Province Maternity and Child Healthcare Hospital

zhoushuguang@ahmu.edu.cn+86 13955117688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026